Your browser doesn't support javascript.
loading
Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study.
Westley, Rosalyne L; Alexander, Sophie E; Goodwin, Edmund; Dunlop, Alex; Nill, Simeon; Oelfke, Uwe; McNair, Helen A; Tree, Alison C.
Afiliación
  • Westley RL; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Alexander SE; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, United Kingdom.
  • Goodwin E; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Dunlop A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, United Kingdom.
  • Nill S; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Oelfke U; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • McNair HA; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
  • Tree AC; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
Front Oncol ; 14: 1379596, 2024.
Article en En | MEDLINE | ID: mdl-38894866
ABSTRACT

Introduction:

We aimed to establish if stereotactic body radiotherapy to the prostate can be delivered safely using reduced clinical target volume (CTV) to planning target volume (PTV) margins on the 1.5T MR-Linac (MRL) (Elekta, Stockholm, Sweden), in the absence of gating.

Methods:

Cine images taken in 3 orthogonal planes during the delivery of prostate SBRT with 36.25 Gray (Gy) in 5 fractions on the MRL were analysed. Using the data from 20 patients, the percentage of radiotherapy (RT) delivery time where the prostate position moved beyond 1, 2, 3, 4 and 5 mm in the left-right (LR), superior-inferior (SI), anterior-posterior (AP) and any direction was calculated.

Results:

The prostate moved less than 3 mm in any direction for 90% of the monitoring period in 95% of patients. On a per-fraction basis, 93% of fractions displayed motion in all directions within 3 mm for 90% of the fraction delivery time. Recurring motion patterns were observed showing that the prostate moved with shallow drift (most common), transient excursions and persistent excursions during treatment.

Conclusion:

A 3 mm CTV-PTV margin is safe to use for the treatment of 5 fraction prostate SBRT on the MRL, without gating. In the context of gating this work suggests that treatment time will not be extensively lengthened when an appropriate gating window is applied.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido